Methylphenidate effective in treating amphetamine abusers with no other psychiatric disorder.
Laqueille
X
X
University Paris V, CH Sainte-Anne, SHU, 1, rue Cabanis, 75674 Paris cedex, France.
Dervaux
A
A
El Omari
F
F
Kanit
M
M
Baylé
F J
FJ
D018663:Adrenergic Agents / Q000627:therapeutic use; D019969:Amphetamine-Related Disorders / Q000150:complications*; D000662:Amphetamines / Q000009:adverse effects; D003866:Depressive Disorder / Q000139:chemically induced* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000150:complications*; D008774:Methylphenidate / Q000627:therapeutic use*; D008875:Middle Aged; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*
D018663:Adrenergic Agents; D000662:Amphetamines; D008774:Methylphenidate